For comments, suggestions
Created with Raphaël 2.1.0 17.06.2016 Filing date 17.01.2018 Validation fee payment 30.06.2018 (A1) Patent application published 29.05.2020 AGEPI application filing date 30.06.2020 (T2) Translation of the validated European patent 31.07.2022 (REC) Correction of name of proprietor 06.06.2025 17.06.2026 Valid until 18.06.2027 Renewal fee to be paid until 17.06.2036 Patent will expire on

Patent in force


(210)Number of the EPO application16733341
(220)Filing date of the EPO application2016.06.17
(80)EPO patent specification publication (B)EPB nr. 18/2020, 2020.04.29
(110)EPO patent number3310333
(11)Number of the documentMD 3310333 T2
(21)Number of the applicatione 2018 0407
(71)Name(s) of applicant(s), code of the countryESTETRA SPRL, BE;
(72)Name(s) of inventor(s), code of the countryJASPART Séverine Francine Isabelle, BE;
PLATTEEUW Johannes Jan, NL;
VAN DEN HEUVEL Denny Johan Marijn, NL;
(73)Name(s) of owner(s), code of the countryEstetra SRL, BE;
(54)Title of the inventionOrodispersible dosage unit containing an estetrol component
(13)Kind-of-document code T2
(51)International Patent Classification A61K 9/20 (2006.01.01); A61K 31/565 (2006.01.01); A61P 15/18 (2006.01.01); A61P 5/00 (2006.01.01)
(19)CountryBE
(41)Date of publication of the application2018.06.30
(49)Date of publication of the translation of the validated European patent specification2020.06.30
(30)Priority15172767, 2015.06.18, EP
(74)Patent attorney(Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova
 Change of the owner
Nr. şi data deciziei:9321, 30.06.2022
Datele iniţiale:ESTETRA SPRL, Belgia;
Datele finale:Estetra SRL, Belgia;
(86)International applicationPCT/EP2016/064065, 2016.06.17
(87)International publicationWO 2016/203006, 2016.12.22
Up
/Inventions/details/3310333